Coronavirus spread will remain under control and specific groups should not be stigmatized, urges microbiologist

Coronavirus spread will remain under control and specific groups should not be stigmatized, urges microbiologist

As the global outbreak of coronavirus continues to dominate the headlines, a leading medical microbiologist from Kingston University says it is inevitable the United Kingdom will see more cases, but emphasized the spread of the virus will remain under control and called on people not to stigmatize particular communities. Professor Mark Fielder, an expert in rapid detection and diagnosis of infectious diseases and antimicrobial resistance, has been studying the likelihood of a new virus emerging through animal to human transmission with his research team. He has been tracking the development of the new coronavirus since it first came to light late last year. This is a virus that spreads quite rapidly but it is one we knew nothing about just over a month ago. We're learning about how it moves and evolves on an almost daily basis. People should be reassured that Britain, along with many other countries, has very good infection control procedures and healthcare processes to make sure we deal with patients safely, carefully and in the best way we can to offer the highest quality treatment and support and the virus is effectively contained." Mark Fielder, Professor, Kingston University The country's strict procedures limit to almost zero the chance of the infection being transmitted on from an infected person once they have been diagnosed, as evidenced by the cases we have seen in the UK so far, Professor Fielder explained. The leading microbiologist - who will be giving a public lecture on the new coronavirus at Kingston University on Thursday 13 February - emphasized the infection does not differentiate between communities or ethnicities and warned against the dangers of stigmatizing specific groups. "We need to make sure we understand this virus and also understand that it doesn't recognize particular communities, individuals or ethnicities - it will infect people where it gets the opportunity. It is a local and global problem that we need to work together to combat," Professor Fielder said. This strain of coronavirus is a newly emerged infection that first came to light in China in late December 2019. It was formally identified by the Chinese Government on January 7 2020. Since then, it has been shown to be an infection that can pass from human to human and at the latest count China had seen more than 42,000 cases. It causes flu-like symptoms in most people, including a cough and high temperature and sometimes shortness of breath. Yet for a healthy person, although they will need medical attention, the impact seems relatively minor and their chances of survival are high, Professor Fielder explained. For the majority of people this is a mild infection. It manifests as a runny nose, fever, maybe a sore throat and a cough. It can descend into tightness of the chest and difficulty in breathing - and possibly then on to pneumonia. However most people who are in generally good health will fully recover - especially if they have medical support." Mark Fielder, microbiologist from Kingston University's Faculty of Science, Engineering and Computing Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More